{"id":5439,"date":"2021-03-16T11:40:01","date_gmt":"2021-03-16T11:40:01","guid":{"rendered":"https:\/\/www.adacyte.com\/professional\/products\/adacolumn\/"},"modified":"2024-07-10T12:31:44","modified_gmt":"2024-07-10T10:31:44","slug":"adacolumn","status":"publish","type":"professional_product","link":"https:\/\/www.adacyte.com\/fr\/professional\/products\/adacolumn\/","title":{"rendered":"Adacolumn\u00ae"},"content":{"rendered":"
\n
\n
\n

Adacolumn\u00ae<\/h1>\n
\n

L\u2019aph\u00e9r\u00e8se leucocytaire (GMA) agit de mani\u00e8re sp\u00e9cifique en emp\u00eachant la migration des granulocytes (neutrophiles) et des monocytes activ\u00e9s vers la paroi intestinale<\/p>\n <\/div>\n <\/div>\n <\/div>\n \n \n \"\"\n <\/picture>\n<\/div>\n

\n
\n
  • <\/path><\/svg><\/span>Int\u00e9r\u00eat de l\u2019utilisation de l\u2019aph\u00e9r\u00e8se leucocytaire (GMA) dans le traitement des MICI<\/a><\/li>
  • <\/path><\/svg><\/span>R\u00f4le des granulocytes et des monocytes dans les MICI<\/a><\/li>
  • <\/path><\/svg><\/span>Aph\u00e9r\u00e8se leucocytaire (GMA)\u00a0: Adacolumn\u00ae<\/a><\/li>
  • <\/path><\/svg><\/span>Pr\u00e9sentation vid\u00e9o Adacolumn\u00ae<\/a><\/li>
  • <\/path><\/svg><\/span>Video MoA Adacolumn\u00ae<\/a><\/li>
  • <\/path><\/svg><\/span>M\u00e9canisme d\u2019action de la GMA<\/a><\/li>
  • <\/path><\/svg><\/span>Indications approuv\u00e9es<\/a><\/li><\/ul>
    • <\/path><\/svg><\/span>Adacolumn\u00ae documents d\u2019information pour les patients<\/a><\/li>
    • <\/path><\/svg><\/span>Information et assistance technique<\/a><\/li>
    • <\/path><\/svg><\/span>Section scientifique<\/a><\/li>
    • <\/path><\/svg><\/span>Temps d\u2019apherese<\/a><\/li>
    • <\/path><\/svg><\/span>Innocuit\u00e9 et contre-indications de la GMA<\/a><\/li>
    • <\/path><\/svg><\/span>En r\u00e9sum\u00e9<\/a><\/li>
    • <\/path><\/svg><\/span>Mode d\u2019emploi<\/a><\/li><\/ul> <\/div>\n <\/div>\n <\/div>\n\n
      \n
      \n
      \n \n